Key statistics
On Wednesday, Edwards Lifesciences Corp (EW*:MEX) closed at 1,433.75, -10.30% below its 52-week high of 1,598.37, set on Jul 24, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1,433.75 |
---|---|
High | 1,433.75 |
Low | 1,433.75 |
Bid | -- |
Offer | 1,433.75 |
Previous close | 1,456.00 |
Average volume | 784.33 |
---|---|
Shares outstanding | 586.60m |
Free float | 584.39m |
P/E (TTM) | 31.52 |
Market cap | 44.81bn USD |
EPS (TTM) | 2.42 USD |
Data delayed at least 20 minutes, as of Jul 09 2025 19:58 BST.
More ▼
Press releases
- Prompt Intervention for Severe Aortic Stenosis Patients Demonstrates Lower Healthcare Costs, Improved Clinical Outcomes
- Edwards Lifesciences to Present at the BofA Securities 2025 Health Care Conference
- Edwards TAVR Receives FDA Approval for Patients With Asymptomatic Severe Aortic Stenosis
- Edwards Lifesciences Reports First Quarter Results
- Eight-Year Data Confirm Long-Term Durability of Edwards’ RESILIA Tissue
- Edwards Lifesciences to Host Earnings Conference Call on April 23, 2025
- Edwards SAPIEN M3 Receives CE Mark, Becoming World’s First Transfemoral Transcatheter Mitral Valve Replacement System
More ▼